CN Patent

CN113683613B — 一种多环吡啶肟基化合物及其药物组合物和用途

Assigned to Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd · Expires 2023-06-09 · 3y expired

What this patent protects

本发明公开了一种多环吡啶肟基化合物及其药物组合物和用途，所述多环吡啶肟基化合物如式(I)所示。该化合物在体外表现出较强的抑制流感病毒活性，并且在生物体肺部对流感病毒有显著的抑制作用，可用于制备抗病毒感染的药物。

USPTO Abstract

本发明公开了一种多环吡啶肟基化合物及其药物组合物和用途，所述多环吡啶肟基化合物如式(I)所示。该化合物在体外表现出较强的抑制流感病毒活性，并且在生物体肺部对流感病毒有显著的抑制作用，可用于制备抗病毒感染的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN113683613B
Jurisdiction
CN
Classification
—
Expires
2023-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.